← All companies

MSLE

Satellos Bioscience Inc.

MSLE Nasdaq Pharmaceutical Preparations EDGAR ↗

$10.03

+0.24 +2.45%

Key statistics

from XBRL data in SEC filings

Market cap

$155M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$4.85 – $13.40

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 8, 2026 6-K FORM 6-K Jun 29, 2026 6-K FORM 6-K Jun 25, 2026 6-K FORM 6-K Jun 18, 2026 6-K FORM 6-K Jun 17, 2026 6-K FORM 6-K May 27, 2026 6-K FORM 6-K May 20, 2026 6-K FORM 6-K May 15, 2026 6-K FORM 6-K Apr 9, 2026 40-F Mar 27, 2026 6-K FORM 6-K Mar 27, 2026 6-K FORM 6-K Mar 10, 2026 6-K FORM 6-K Feb 24, 2026 6-K FORM 6-K Feb 19, 2026 6-K FORM 6-K Feb 18, 2026 6-K FORM 6-K Feb 17, 2026 6-K FORM 6-K Feb 12, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Feb 10, 2026 6-K FORM 6-K Feb 6, 2026

Other filings

SCHEDULE 13G May 15, 2026 SCHEDULE 13G May 12, 2026 S-8 FORM S-8 Mar 27, 2026 SUPPL Feb 6, 2026 CERT Feb 6, 2026 8-A12B Feb 5, 2026 F-X FORM F-X Feb 5, 2026 F-10 Feb 5, 2026 D Item 06b Jan 3, 2025 D Item 06b May 25, 2023 D Item 06b Sep 27, 2022 D Item 06b Sep 10, 2019 D Item 06b Mar 8, 2019 D Item 06b Feb 5, 2014 D/A Item 06b Nov 21, 2013 D Item 06 Nov 15, 2011 D/A Item 06 Dec 1, 2009 D Item 06 Nov 6, 2009 REGDEX Item 06 Mar 12, 2009 REGDEX Item 06 Dec 17, 2007